|  | 
|---|
| Receptor (ligands)
 | | CB1Tooltip Cannabinoid receptor type 1 | | Agonists (abridged,
 full list)
 |  | 
|---|
 | Inverse agonists |  | 
|---|
 | Antagonists |  | 
|---|
 | 
|---|
 | CB2Tooltip Cannabinoid receptor type 2 | | Agonists | 
2-AG2-AGE (noladin ether)3,3'-Diindolylmethane4-O-Methylhonokiolα-Amyrin · β-AmyrinA-796,260A-834,735A-836,339AM-1172AM-1221AM-1235AM-1241AM-2232AnandamideAZ-11713908CannabinolCaryophylleneCB-13CBS-0550CP 55,940GW-405,833 (L-768,242)GW-842,166XHU-308JTE 7-31JWH-007JWH-015JWH-018JWH-73JWH-133L-759,633L-759,656Lenabasum (anabasum)MagnololMDA-19NabitanNADAOlorinab (APD-371)PF-03550096S-444,823SER-601Serinolamide AUR-144TedalinabTHC (dronabinol)THCVTetrahydromagnololVirodhamine
 | 
|---|
 | Antagonists |  | 
|---|
 | 
|---|
 | NAGly (GPR18)
 |  | 
|---|
 | GPR55 |  | 
|---|
 | GPR119 |  | 
|---|
 | 
|---|
| Transporter (modulators)
 | | eCBTsTooltip Endocannabinoid transporter |  | 
|---|
 | 
|---|
| Enzyme (modulators)
 |  | 
|---|
| Others | 
Others: 2-PG (directly potentiates activity of 2-AG at CB1 receptor)ARN-272 (FAAH-like anandamide transporter inhibitor)
 | 
|---|
|  |